Conducting Clinical Trials During COVID-19: Lessons for the Next Pandemic, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speakers will discuss how management of clinical trials has changed during this year, how we drove clinical trials for vaccines and treatment as well as adaptations for R&D and testing capabilities. The presenters will also discuss how agile we need to be to face new viruses as well as the importance of genetics studies and predictive biomarker testing to better understand who could develop the most severe symptoms.

We are still working on predictive biomarker testing to identify people who are at the most risk of developing severe symptoms, epidemiological, vaccine and genetic studies.

The coronavirus is not the first infectious disease that has forced clinical trials to adapt. Zika, Ebola and other diseases called for the world to adjust and collaborate global research efforts. With COVID-19, the rapid spread and impact on global healthcare systems forced us to change our trial management and accelerate our processes like never before. The global research community have already discovered and developed several tests and vaccines in record time through collaboration. Yet we are still working on predictive biomarker testing to identify people who are at the most risk of developing severe symptoms, epidemiological, vaccine and genetic studies.

To facilitate testing, research and innovation and to ensure trials continued, we adapted our capabilities and facilities to push research continuity.

Register for this webinar to learn the answers to these questions:

  • Did we succeed, how fast did we adapt and are we ready to face a new pandemic crisis in the future?
  • How did we maintain the high security and confidence of testing, and what did our reactivity and proactivity mean in the context of a health crisis?

Join experts from Cerba Research, Benedicte Roquebert, PhD, Biologist; Souad Mehlal, PhD, Biologist; Lisa Slachmuylders, PharmD, PhD, Therapeutic Area Expert in Infectious Diseases; and Stéphanie Haim-Boukobza, PhD, Biologist, for the live webinar on Wednesday, May 12, 2021 at 10am EDT (3pm BST/UK).

For more information, or to register for this event, visit Conducting Clinical Trials During COVID-19: Lessons for the Next Pandemic.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ayesha Rashid
Xtalks
+1 (416) 977-6555 x 272
Email >
Visit website